MariMed Inc. (MRMD.CN)
CAD 0.15
(-11.76%)
CAD 0.15
(-11.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -16.03 Million USD | -219.03% |
| 2022 | 13.46 Million USD | 86.41% |
| 2021 | 7.22 Million USD | 236.99% |
| 2020 | 2.14 Million USD | 103.22% |
| 2019 | -66.51 Million USD | -248.82% |
| 2018 | -19.06 Million USD | -1496.99% |
| 2017 | -1.19 Million USD | -500.49% |
| 2016 | -198.85 Thousand USD | 83.64% |
| 2015 | -1.21 Million USD | 83.17% |
| 2014 | -7.21 Million USD | -1247.92% |
| 2013 | -535.6 Thousand USD | 33.84% |
| 2012 | -809.54 Thousand USD | -114.5% |
| 2011 | -377.41 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.65 Million USD | -27.2% |
| 2024 Q1 | -1.29 Million USD | 87.24% |
| 2023 Q2 | -958 Thousand USD | -44.28% |
| 2023 Q4 | -10.16 Million USD | -138.76% |
| 2023 Q1 | -664 Thousand USD | -113.98% |
| 2023 Q3 | -4.25 Million USD | -344.57% |
| 2023 FY | -16.03 Million USD | -219.03% |
| 2022 Q1 | 4.18 Million USD | 165.46% |
| 2022 Q3 | 2.7 Million USD | 48.44% |
| 2022 Q4 | 4.75 Million USD | 75.57% |
| 2022 FY | 13.46 Million USD | 86.41% |
| 2022 Q2 | 1.82 Million USD | -56.47% |
| 2021 Q2 | 7.49 Million USD | 77.56% |
| 2021 Q4 | -6.39 Million USD | -416.74% |
| 2021 Q1 | 4.21 Million USD | 2.41% |
| 2021 FY | 7.22 Million USD | 236.99% |
| 2021 Q3 | 2.02 Million USD | -73.04% |
| 2020 FY | 2.14 Million USD | 103.22% |
| 2020 Q1 | -2.42 Million USD | 96.91% |
| 2020 Q2 | -1.21 Million USD | 49.86% |
| 2020 Q3 | 1.65 Million USD | 236.64% |
| 2020 Q4 | 4.12 Million USD | 148.4% |
| 2019 Q1 | -23.21 Thousand USD | -100.48% |
| 2019 Q4 | -78.43 Million USD | -960.19% |
| 2019 Q3 | -7.39 Million USD | -258.19% |
| 2019 FY | -66.51 Million USD | -248.82% |
| 2019 Q2 | 4.67 Million USD | 20250.3% |
| 2018 Q2 | -6.34 Million USD | -234.95% |
| 2018 Q4 | 4.84 Million USD | 147.45% |
| 2018 Q1 | -1.89 Million USD | -43.96% |
| 2018 FY | -19.06 Million USD | -1496.99% |
| 2018 Q3 | -10.2 Million USD | -60.73% |
| 2017 FY | -1.19 Million USD | -500.49% |
| 2017 Q4 | -1.31 Million USD | -235.43% |
| 2017 Q1 | -32.24 Thousand USD | -384.38% |
| 2017 Q2 | 547 Thousand USD | 1796.65% |
| 2017 Q3 | -392.45 Thousand USD | -171.75% |
| 2016 Q1 | -100.53 Thousand USD | 81.79% |
| 2016 FY | -198.85 Thousand USD | 83.64% |
| 2016 Q4 | 11.33 Thousand USD | 118.64% |
| 2016 Q3 | -60.82 Thousand USD | -19.29% |
| 2016 Q2 | -50.98 Thousand USD | 49.29% |
| 2015 Q1 | -208.19 Thousand USD | 94.08% |
| 2015 Q3 | -118.16 Thousand USD | 64.93% |
| 2015 FY | -1.21 Million USD | 83.17% |
| 2015 Q4 | -552.02 Thousand USD | -367.16% |
| 2015 Q2 | -336.95 Thousand USD | -61.85% |
| 2014 Q4 | -3.51 Million USD | -2.08% |
| 2014 FY | -7.21 Million USD | -1247.92% |
| 2014 Q3 | -3.44 Million USD | -2681.22% |
| 2014 Q2 | -123.88 Thousand USD | 6.16% |
| 2014 Q1 | -132 Thousand USD | 13.31% |
| 2013 Q3 | -85.48 Thousand USD | 31.82% |
| 2013 Q4 | -152.28 Thousand USD | -78.15% |
| 2013 FY | -535.6 Thousand USD | 33.84% |
| 2013 Q1 | -172.47 Thousand USD | 55.0% |
| 2013 Q2 | -125.36 Thousand USD | 27.31% |
| 2012 Q3 | -181.97 Thousand USD | -24.94% |
| 2012 Q4 | -383.25 Thousand USD | -110.61% |
| 2012 Q2 | -145.64 Thousand USD | -47.62% |
| 2012 Q1 | -98.66 Thousand USD | 0.0% |
| 2012 FY | -809.54 Thousand USD | -114.5% |
| 2011 Q2 | -266.95 Thousand USD | 0.0% |
| 2011 FY | -377.41 Thousand USD | 0.0% |
| 2011 Q3 | -98.35 Thousand USD | 63.16% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.28 Million CAD | -154.979% |
| Ayurcann Holdings Corp. | -3.96 Million CAD | -304.034% |
| Blueberries Medical Corp. | -1.63 Million CAD | -880.265% |
| The BC Bud Corporation | -1.22 Million CAD | -1209.662% |
| BioNxt Solutions Inc. | -7.72 Million CAD | -107.577% |
| CordovaCann Corp. | -6.88 Million CAD | -132.851% |
| Christina Lake Cannabis Corp. | -4.13 Million CAD | -287.988% |
| Captor Capital Corp. | -11.38 Million CAD | -40.858% |
| City View Green Holdings Inc. | -2.44 Million CAD | -554.703% |
| 1CM Inc. | -913.85 Thousand CAD | -1654.213% |
| Global Hemp Group Inc. | -2.58 Million CAD | -521.228% |
| Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | -239.448% |
| IM Cannabis Corp. | -9.49 Million CAD | -68.783% |
| Lobe Sciences Ltd. | -4.7 Million CAD | -240.553% |
| Maple Leaf Green World Inc. | -1.09 Million CAD | -1368.676% |
| Mountain Valley MD Holdings Inc. | -7.67 Million CAD | -109.009% |
| Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 7278.038% |
| Ovation Science Inc. | -813.14 Thousand CAD | -1871.471% |
| Pharmadrug Inc. | -13.2 Million CAD | -21.435% |
| Captiva Verde Wellness Corp. | -6.08 Million CAD | -163.446% |
| RAMM Pharma Corp. | -7.72 Million CAD | -107.631% |
| RIV Capital Inc. | -106.76 Million CAD | 84.984% |
| Revive Therapeutics Ltd. | -5.61 Million CAD | -185.319% |
| Red White & Bloom Brands Inc. | -138.89 Million CAD | 88.458% |
| SLANG Worldwide Inc. | -19.36 Million CAD | 17.222% |
| 1933 Industries Inc. | -13.36 Million CAD | -19.957% |
| Red Light Holland Corp. | -7.62 Million CAD | -110.18% |
| Top Strike Resources Corp. | -1.72 Million CAD | -832.018% |
| Xebra Brands Ltd. | -1.95 Million CAD | -719.003% |
| Adastra Holdings Ltd. | -3.54 Million CAD | -352.26% |